Asieris Pharmaceuticals Enrolls First Patient in Phase II Study for APL-1202
China-based Asieris Pharmaceuticals (SHA: 688176) announced the first patient enrollment in a Phase II clinical...
Jiangsu Yahong Administers First Dose of Hexvix in Hainan Pilot Zone
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) announced the first...
Ascletis Pharma Announces Positive Phase I Results for ASC10 in COVID-19 Treatment
China-based Ascletis Pharma Inc., (HKG: 1672) announced the positive topline results from its Phase I...
Yantai Dongcheng to Acquire US Firm XingImaging for $30.2M
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) is set to acquire a 100%...
Hotgen Biotech’s COVID-19 Antigen Home Test Approved in Russia
China-based Hotgen Biotech Co., Ltd (SHA: 688068) announced receiving market approval in Russia for its...
Angel Pharmaceuticals Presents CPI-818 Data at ASH 2022 Annual Meeting
China-based Angel Pharmaceuticals Ltd announced the latest results of the global Phase I/Ib clinical study...
ClinBrain and WCH Establish Joint Laboratory for Geriatric Information Platform
Shanghai-based ClinBrain, a clinical data repository (CDR) and medical big data services provider, together with...
Wuhan YZY Biopharma Files for IPO on Hong Kong Stock Exchange
China-based Wuhan YZY Biopharma Co., Ltd, a biopharmaceutical company focused on targeted cancer drugs and...
JW Therapeutics Presents Carteyva Data at ASH Annual Meeting
China-based JW Therapeutics (HKG: 2126) presented the latest clinical data on Carteyva (relmacabtagene autoleucel injection)...
4B Technologies Raises RMB 100M in Pre-Series B Financing Round
China-based 4B Technologies Investments Ltd, a biotech focused on central nervous system (CNS) drug development,...
Gaush Meditech IPOs on Hong Kong Stock Exchange at HKD 21.4 per Share
China-based Gaush Meditech Ltd reportedly made an initial public offering (IPO) at the Hong Kong...
Northeast Pharmaceutical Fined RMB 133M for Monopoly Selling
Northeast Pharmaceutical Co., Ltd (SHE: 000597) was fined RMB 133 million (USD 19m) by the...
Dizal Pharma Presents Golidocitinib Data at ASH Annual Meeting
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) presented the latest clinical data on golidocitinib (DZD4205)...
HitGen and Nitrase Therapeutics Enter Research Agreement
China-based HitGen Inc. (SHA: 688222) announced a research agreement with US firm Nitrase Therapeutics, Inc....
Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research
Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences...
Innoforce Partners with RNAimmune for mRNA Development and Production
Hangzhou-based biopharma partner company Innoforce Pharmaceuticals Co., Ltd struck a partnership with RNAimmune, a spin-off...
NMPA Approves COVID-19 Antigen Detection Reagents from Four Companies
The National Medical Products Administration (NMPA) announced the marketing approvals for COVID-19 antigen detection reagents...
Biozon Partners with Agilent Technologies to Boost ICP-MS in China Clinics
Zhejiang-based third-party detection service company Biozon struck a partnership with US firm Agilent Technologies. The...
Sino Biopharmaceutical’s ATR Kinase Inhibitor TCC1727 Accepted for FDA Review
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acceptance for review of its Investigational New...
Acotec Scientific and Boston Scientific Enter Acquisition and Collaboration Agreement
China-based Acotec Scientific Holdings Ltd (HKG: 6669) and US major Boston Scientific Corporation (NYSE: BSX)...